Health Condition 1: H401- Open-angle glaucoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of POAG Age more than 40 years BCVA more than 6 by 12 in both eyes Literate, educated up to 5th standard Willing to participate in study
Exclusion criteria
Exclusion criteria: Patients with other forms of glaucoma Age less than 40 years BCVA less than 6 by 12 in either eye Eye disease other than glaucoma that could have affected RNFL and GC-IPL thickness, such as macular degeneration and optic neuropathy Patients on systemic medications which could affect cognition example BZPs, Opiates, TCAs, Anticonvulsants and Dopamine agonists. Patients with diagnosed neurological or psychiatric disease. Patients with chronic systemic disease such as Diabetes, Coronary Artery Disease or Cerebrovascular Disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the change in cognitive functioning after tDCS in individuals with Primary Open Angle Glaucoma (POAG)Timepoint: At baseline and follow up at 1 month and 3 month | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the association of cognitive functioning in POAG with Quality of life using EuroQol (EQ-5D-5L) To evaluate the association of cognitive functioning in POAG with Retinal nerve fiber layer (RNFL) and Ganglion cell layer (GCC) on Optical Coherence Tomography(OCT) Visual field sensitivity on Automated Perimetry Endogenous cortisol levels Timepoint: At baseline and follow up at 1 month and 3 month | — |
Countries
India
Contacts
DR R.P CENTRE OF OPHTHALMIC SCIENCES NEW DELHI